PharmaCielo Ratios and Metrics

Market cap in millions CAD. Fiscal year is April - March.

Millions CAD. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2026	FY 2025	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 10, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	14	8	12	30	27	146
Market Cap Growth	62.35%	-34.48%	-59.87%	12.26%	-81.46%	-49.31%
Enterprise Value	31.87	26.14	34.4	48.69	39.38	149.08
Last Close Price	0.07	0.04	0.07	0.18	0.18	0.98
Forward PE	-	9.08	9.08	9.08	9.08	9.08
PS Ratio	5.41	3.16	3.08	19.75	5.11	75.21
PB Ratio	-1.25	-0.73	-1.29	-18.13	4.24	7.57
P/TBV Ratio	-	-	-	-	4.13	7.39
EV/Sales Ratio	12.57	10.31	8.67	31.58	7.42	76.65
Debt / Equity Ratio	-	0	-0.49	-1.52	1.84	0.42
Net Debt / Equity Ratio	-1.65	-1.65	-2.34	-10.86	1.92	0.14
Net Debt / EBITDA Ratio	-6.98	-6.98	-3.98	-1.42	-1.10	-0.12
Net Debt / FCF Ratio	-3.93	-3.93	-10.53	-3.53	-1.18	-0.13
Asset Turnover	0.24	0.16	0.21	0.07	0.17	0.05
Inventory Turnover	0.98	1.09	2.56	1.31	2.10	3.45
Quick Ratio	0.01	0.01	0.02	0.01	0.13	0.73
Current Ratio	0.15	0.15	0.10	0.16	0.58	1.14
Return on Equity (ROE)	3.69%	37.77%	126.10%	-691.70%	-112.89%	-116.87%
Return on Assets (ROA)	-31.61%	-21.48%	-38.94%	-60.24%	-41.60%	-62.60%
Return on Invested Capital (ROIC)	-	-	-	-146.23%	-62.30%	-114.00%
Return on Capital Employed (ROCE)	25.36%	42.14%	148.24%	-150.00%	-55.17%	-83.65%
Buyback Yield / Dilution	-8.09%	-8.09%	-8.93%	-6.03%	-3.67%	-29.41%
Total Shareholder Return	-8.09%	-8.09%	-8.93%	-6.03%	-3.67%	-29.41%